82
Participants
Start Date
July 16, 2018
Primary Completion Date
June 2, 2022
Study Completion Date
June 3, 2022
German cockroach allergenic extract
Active ingredient: a non-standardized allergen derived from the extraction and purification of proteins from German cockroach (Blattella germanica). Non-standardized glycerinated German cockroach allergenic extract is approved in the United States for diagnostic skin testing and immunotherapy by subcutaneous injection (U.S. License 467).
Placebo for German cockroach allergenic extract
Commercially- labeled licensed product, sterile diluent for allergenic extract (50% glycerinated), sodium bicarbonate (0.091%) sodium chloride (0.166%).
Icahn School of Medicine at Mount Sinai, New York
Columbia University Medical Center, New York
Children's National Medical Center - IMPACT DC, Washington D.C.
Johns Hopkins University, Baltimore
Henry Ford Health System: Division of Allergy and Immunology, Detroit
Ann and Robert Lurie Children's Hospital of Chicago, Chicago
St. Louis Children's Hospital: Allergy, Immunology and Pulmonary Medicine Program, St Louis
Children's Hospital Colorado, Aurora
Boston Medical Center, Boston
Cincinnati Children's Hospital, Cincinnati
University of Texas Southwestern Medical School, Dallas
Inner-City Asthma Consortium
NETWORK
Rho Federal Systems Division, Inc.
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH